Persistent analgesic use and the association with chronic pain and other risk factors in the population—a longitudinal study from the Tromsø Study and the Norwegian Prescription Database

[1]  A. Pottegård,et al.  Acetaminophen for Chronic Pain: A Systematic Review on Efficacy. , 2016, Basic & clinical pharmacology & toxicology.

[2]  A. S. Rosario,et al.  Prevalence, trends, patterns and associations of analgesic use in Germany , 2015, BMC Pharmacology and Toxicology.

[3]  A. Eggen,et al.  Analgesic use in a Norwegian general population: change over time and high-risk use - The Tromsø Study , 2015, BMC Pharmacology and Toxicology.

[4]  R. Chou,et al.  The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop , 2015, Annals of Internal Medicine.

[5]  B. Guthrie,et al.  Changes in opioid and other analgesic use 1995–2010: Repeated cross‐sectional analysis of dispensed prescribing for a large geographical population in Scotland , 2015, European journal of pain.

[6]  A. Tanskanen,et al.  From prescriptions to drug use periods - things to notice , 2014, BMC Research Notes.

[7]  P. Romundstad,et al.  Chronic pain and use of opioids: A population-based pharmacoepidemiological study from the Norwegian Prescription Database and the Nord-Trøndelag Health Study , 2014, PAIN®.

[8]  S. Atlas,et al.  Opioids Compared With Placebo or Other Treatments for Chronic Low Back Pain: An Update of the Cochrane Review , 2014, Spine.

[9]  P. Romundstad,et al.  Persistent opioid use and socio‐economic factors: a population‐based study in Norway , 2014, Acta anaesthesiologica Scandinavica.

[10]  A. Freedman,et al.  Trends in the use of aspirin and nonsteroidal anti‐inflammatory drugs in the general U.S. population , 2014, Pharmacoepidemiology and drug safety.

[11]  M. Menchetti,et al.  Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence , 2013, European Journal of Clinical Pharmacology.

[12]  P. Romundstad,et al.  Longitudinal Associations between Exercise and Pain in the General Population - The HUNT Pain Study , 2013, PloS one.

[13]  E. Kalso,et al.  Expect analgesic failure; pursue analgesic success , 2013, BMJ.

[14]  C. Terwee,et al.  Spinal Manipulative Therapy for Acute Low Back Pain: An Update of the Cochrane Review , 2013, Spine.

[15]  A. Eggen,et al.  The sixth survey of the Tromsø Study (Tromsø 6) in 2007–08: Collaborative research in the interface between clinical medicine and epidemiology: Study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey , 2013, Scandinavian journal of public health.

[16]  A. Pripp,et al.  Are sleep problems and non-specific health complaints risk factors for chronic pain? A prospective population-based study with 17 year follow-up , 2012, Scandinavian journal of pain.

[17]  P. Romundstad,et al.  Estimating the prevalence of chronic pain: Validation of recall against longitudinal reporting (the HUNT pain study) , 2012, Pain.

[18]  P. Romundstad,et al.  Differential patterns of opioid use: Defining persistent opioid use in a prescription database , 2012, European journal of pain.

[19]  Tom Wilsgaard,et al.  Cohort profile: The Tromsø Study , 2011, International journal of epidemiology.

[20]  L. Paulozzi,et al.  A population-based survey of chronic pain and its treatment with prescription drugs , 2011, PAIN.

[21]  K. Hamunen,et al.  Choosing the unit of measurement counts: The use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses , 2011, Palliative medicine.

[22]  L. Annemans.  Pharmacoeconomic Impact of Adverse Events of Long-Term Opioid Treatment for the Management of Persistent Pain , 2011 .

[23]  S. Kjaer,et al.  Factors associated with a continuous regular analgesic use—a population‐based study of more than 45 000 Danish women and men 18–45 years of age , 2010, Pharmacoepidemiology and drug safety.

[24]  C. Rutter,et al.  Trends in long‐term opioid therapy for chronic non‐cancer pain , 2009, Pharmacoepidemiology and drug safety.

[25]  K. Furu.  Establishment of the nationwide Norwegian Prescription Database (NorPD) – new opportunities for research in pharmacoepidemiology in Norway , 2008 .

[26]  C. Rutter,et al.  De Facto Long-term Opioid Therapy for Noncancer Pain , 2008, The Clinical journal of pain.

[27]  S. Galea,et al.  Participation rates in epidemiologic studies. , 2007, Annals of epidemiology.

[28]  E. Bruera,et al.  Critical issues on opioids in chronic non-cancer pain: An epidemiological study , 2006, Pain.

[29]  S. Morgan,et al.  Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization. , 2006, Clinical therapeutics.

[30]  B. Collett,et al.  Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.

[31]  A. Lerdal,et al.  Prevalence and characteristics of chronic pain in the general Norwegian population , 2004, European journal of pain.

[32]  O. Ekholm,et al.  Epidemiology of chronic non-malignant pain in Denmark , 2003, Pain.

[33]  R. Huupponen,et al.  Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland , 2003, European Journal of Clinical Pharmacology.

[34]  O. Dalgard,et al.  Measuring the mental health status of the Norwegian population: A comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36) , 2003, Nordic journal of psychiatry.

[35]  F. Ponti,et al.  Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement , 2003, European Journal of Clinical Pharmacology.

[36]  A. Silman,et al.  Does chronic pain predict future psychological distress? , 2002, Pain.

[37]  P. Gøtzsche,et al.  Non-steroidal anti-inflammatory drugs , 2000, BMJ : British Medical Journal.

[38]  M. Hotopf,et al.  Temporal relationships between physical symptoms and psychiatric disorder , 1998, British Journal of Psychiatry.

[39]  A. Eggen.  The use of controlled analgesics in a general population (15‐59 years) — the influence of age, gender, morbidity, lifestyle and sociodemographic factors , 1996, Pharmacoepidemiology and drug safety.

[40]  A. Eggen.  The Tromsø Study: frequency and predicting factors of analgesic drug use in a free-living population (12-56 years). , 1993, Journal of clinical epidemiology.

[41]  H. Sutton.  AN EPIDEMIOLOGICAL STUDY , 1937 .